• Wellness Wearables Face a Higher Bar for Supporting Evidence, Experts Say

    Clinical Research News | As consumer health wearables move closer to medical territory, product makers need clinical data that supports their claims, whether or not they plan to seek FDA clearance, according to regulatory and clinical research experts at DCN Dx.

    Nov 12, 2026
  • Last-Mile Hurdles in Putting AI into Real-World Clinical Research

    Clinical Research News | Implementing an artificial intelligence (AI) policy at the highest levels of a clinical research organization requires middle managers empowered and equipped to carry it out companywide. But not every AI workflow deserves the same level of scrutiny, according to Marc Wartenberger, vice president of compliance and security at CRIO, who moderated a panel discussion on the policy-to-practice issues at the recent SCOPE Europe event in Barcelona.

    Nov 10, 2026
  • Has Detailing AI’s Reasoning Become Confused With The Tech’s Safety in a PV Context?

    Clinical Research News | For any life sciences organization keen to establish appropriate guardrails around their AI use, recent debate about preventing AI’s potential harms has helped frame some of the critical parameters. Previously, too much of the “trusted AI” discussion has centered on the ability to explain how AI has arrived at its conclusions. But this quality alone does not make for robust governance, especially where patient safety is at stake.

    Nov 6, 2026
  • Flatiron Building ‘Continuous Intelligence Engine’ for Cancer Research

    Clinical Research News | Flatiron Health is building a global oncology intelligence engine that is poised to change how research gets done by scaling data collection and speeding up how researchers extract evidence. The platform, known as Flatiron Telescope, is designed to enable anyone working in oncology to answer questions faster at any stage of drug development.

    Nov 5, 2026
  • Nouscom Funds Registration Trial, AnaCardio Backs Phase 2b

    Clinical Research News | KymaThera's $80M Series B carries K-1728 into Phase 1; Microbiotica raises £36M to take MB310 into Phase 2 for ulcerative colitis; Altay Therapeutics closes $37M for Phase 1 and Phase 2 trials in FSHD; and more.

    Oct 28, 2026
  • Oracle Partners with AstraZeneca on AI Trials, IQVIA Expands Veeva Deal, FutureMeds Acquires Hera

    Clinical Research News | Peppermint raises $4.7 million to speed payments to clinical trial sites; Clinisys adds document intelligence to its laboratory platform; and more.

    Oct 27, 2026